Metastatic Castration Resistant Prostate Cancer

Last updated: August 6, 2021
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

N/A

Condition

Prostate Cancer

Treatment

N/A

Clinical Study ID

TX279281
  • Ages 18-100
  • All Genders

Study Summary

People with Prostate Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Are a male or female at least 18 years of age
  • Have histologically or cytologically confirmed adenocarcinoma of the prostate
  • Have metastatic prostate cancer disease
  • Are surgically or medically castrated
  • Have had no prior treatment with cytotoxic chemotherapy
  • Demonstrate adequate organ function

Exclusion

Exclusion Criteria:

  • Have known symptomatic brain metastases.
  • Have clinically significant cardiovascular disease
  • Have untreated or impending spinal cord compression
  • Have a severe concurrent disease, infection, or comorbidity
  • Have a history of seizure
  • Have had major surgery within 4 weeks
  • Have known immunodeficiency virus (HIV) infection, hepatitis B or C

Study Design

Study Start date:
August 06, 2021
Estimated Completion Date:

Study Description

People with Prostate Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Connect with a study center

  • Biomedical Research Alliance of New York

    Bronx, New York 10461
    United States

    Active - Recruiting

  • Biomedical Research Alliance of New York LLC

    Bronx, New York 10461
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.